AAAAAA
Results:
1-17
|
Results: 17
Authors:
EHRMANN DA
Citation: Da. Ehrmann, ATTENUATION OF HYPERINSULINEMIA IN POLYCYSTIC-OVARY-SYNDROME - WHAT ARE THE OPTIONS, Journal of endocrinological investigation, 21(9), 1998, pp. 632-635
Authors:
CAVAGHAN MK
EHRMANN DA
POLONSKY KS
Citation: Mk. Cavaghan et al., ELEVATED FREE FATTY-ACIDS IMPAIR BETA-CELL GLUCOSE SENSING DESPITE HYPERSECRETION OF INSULIN IN OBESE SUBJECTS WITH NORMAL AND IMPAIRED GLUCOSE-TOLERANCE, Diabetes, 47, 1998, pp. 181-181
Authors:
EHRMANN DA
Citation: Da. Ehrmann, RELATION OF FUNCTIONAL OVARIAN HYPERANDROGENISM TO NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Bailliere's clinical obstetrics and gynaecology, 11(2), 1997, pp. 335-347
Authors:
CAVAGHAN MK
EHRMANN DA
BYRNE MM
POLONSKY KS
Citation: Mk. Cavaghan et al., TREATMENT WITH THE ORAL ANTIDIABETIC AGENT TROGLITAZONE IMPROVES BETA-CELL RESPONSES TO GLUCOSE IN SUBJECTS WITH IMPAIRED GLUCOSE-TOLERANCE, The Journal of clinical investigation, 100(3), 1997, pp. 530-537
Authors:
EHRMANN DA
SCHNEIDER DJ
SOBEL BE
CAVAGHAN MK
IMPERIAL J
ROSENFIELD RL
POLONSKY KS
Citation: Da. Ehrmann et al., TROGLITAZONE IMPROVES DEFECTS IN INSULIN ACTION, INSULIN-SECRETION, OVARIAN STEROIDOGENESIS, AND FIBRINOLYSIS IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2108-2116
Authors:
BARNES RB
EHRMANN DA
Citation: Rb. Barnes et Da. Ehrmann, CLINICAL CASE SEMINAR - LONG-TERM SUPPRESSION OF TESTOSTERONE AFTER TREATMENT WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST IN A WOMAN WITHA PRESUMED TESTOSTERONE SECRETING OVARIAN TUMOR, The Journal of clinical endocrinology and metabolism, 82(6), 1997, pp. 1746-1748
Authors:
EHRMANN DA
CAVAGHAN MK
IMPERIAL J
STURIS J
ROSENFIELD RL
POLONSKY KS
Citation: Da. Ehrmann et al., EFFECTS OF METFORMIN ON INSULIN-SECRETION, INSULIN ACTION, AND OVARIAN STEROIDOGENESIS IN WOMEN WITH POLYCYSTIC-OVARY-SYNDROME, The Journal of clinical endocrinology and metabolism, 82(2), 1997, pp. 524-530
Authors:
CAVAGHAN MK
EHRMANN DA
BYRNE MM
POLONSKY KS
Citation: Mk. Cavaghan et al., TREATMENT WITH THE ORAL ANTIDIABETIC AGENT TROGLITAZONE IMPROVES BETA-CELL RESPONSES TO GLUCOSE IN SUBJECTS WITH IGT, Diabetes, 46, 1997, pp. 834-834
Authors:
RAFFEL LJ
ROBBINS DC
NORRIS JM
BOERWINKLE E
DEFRONZO RA
ELBEIN SC
FUJIMOTO W
HANIS CL
KAHN SE
PERMUTT MA
CHIU KC
CRUZ J
EHRMANN DA
ROBERTSON RP
ROTTER JI
BUSE J
Citation: Lj. Raffel et al., THE GENNID STUDY - A RESOURCE FOR MAPPING THE GENES THAT CAUSE NIDDM, Diabetes care, 19(8), 1996, pp. 864-872
Authors:
ROSENFIELD RL
PEROVIC N
EHRMANN DA
BARNES RB
Citation: Rl. Rosenfield et al., ACUTE HORMONAL RESPONSES TO THE GONADOTROPIN-RELEASING-HORMONE AGONIST LEUPROLIDE - DOSE-RESPONSE STUDIES AND COMPARISON TO NAFARELIN - A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 81(9), 1996, pp. 3408-3411
Authors:
EHRMANN DA
BARNES RB
ROSENFIELD RL
Citation: Da. Ehrmann et al., POLYCYSTIC-OVARY-SYNDROME AS A FORM OF FUNCTIONAL OVARIAN HYPERANDROGENISM DUE TO DYSREGULATION OF ANDROGEN SECRETION, Endocrine reviews, 16(3), 1995, pp. 322-353
Authors:
EHRMANN DA
STURIS J
BYRNE MM
KARRISON T
ROSENFIELD RL
POLONSKY KS
Citation: Da. Ehrmann et al., INSULIN SECRETORY DEFECTS IN POLYCYSTIC-OVARY-SYNDROME - RELATIONSHIPTO INSULIN SENSITIVITY AND FAMILY HISTORY OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS, The Journal of clinical investigation, 96(1), 1995, pp. 520-527
Authors:
ROSENFIELD RL
BARNES RB
EHRMANN DA
CARA JF
CUTTLER L
LEVITSKY LL
ROSENTHAL IM
Citation: Rl. Rosenfield et al., FUNCTIONAL OVARIAN HYPERANDROGENISM (FOH) AS A RESULT OF CONGENITAL ADRENAL VIRILIZING DISORDERS (CAVD) - EVIDENCE FOR PERINATAL MASCULINIZATION OF NEUROENDOCRINE FUNCTION IN MAN, Pediatric research, 35(4), 1994, pp. 10000106-10000106
Authors:
ROSENFIELD RL
BARNES RB
EHRMANN DA
Citation: Rl. Rosenfield et al., STUDIES OF THE NATURE OF 17-HYDROXYPROGESTERONE HYPERRESPONSIVENESS TO GONADOTROPIN-RELEASING-HORMONE AGONIST CHALLENGE IN FUNCTIONAL OVARIAN HYPERANDROGENISM, The Journal of clinical endocrinology and metabolism, 79(6), 1994, pp. 1686-1692
Authors:
BARNES RB
ROSENFIELD RL
EHRMANN DA
CARA JF
CUTTLER L
LEVITSKY LL
ROSENTHAL IM
Citation: Rb. Barnes et al., OVARIAN HYPERANDROGYNISM AS A RESULT OF CONGENITAL ADRENAL VIRILIZINGDISORDERS - EVIDENCE FOR PERINATAL MASCULINIZATION OF NEUROENDOCRINE FUNCTION IN WOMEN, The Journal of clinical endocrinology and metabolism, 79(5), 1994, pp. 1328-1333
Authors:
BARNES RB
ROSENFIELD RL
EHRMANN DA
Citation: Rb. Barnes et al., DYSREGULATION OF 17-HYDROXYLASE AND 17,20-LYASE IN FUNCTIONAL OVARIANHYPERANDROGENISM, Seminars in reproductive endocrinology, 11(4), 1993, pp. 334-340
Authors:
OMEARA NM
BLACKMAN JD
EHRMANN DA
BARNES RB
JASPAN JB
ROSENFIELD RL
POLONSKY KS
Citation: Nm. Omeara et al., DEFECTS IN BETA-CELL FUNCTION IN FUNCTIONAL OVARIAN HYPERANDROGENISM, The Journal of clinical endocrinology and metabolism, 76(5), 1993, pp. 1241-1247
Risultati:
1-17
|